Craig Coleman
Professor/Pharmacy Practice

Are you Craig Coleman?

How to update your information.
Scholarly Contributions

620 Scholarly Contributions

419
Journal Articles
137
Poster/Presentations
41
Other Scholarly Works
12
Digital and Electronic Media, Social Media, Blog, Podcast, Magazine/Trade Publications
6
Conference Proceedings
5
Book Chapters
Efficacy and Safety of Antihyperglycemic Agents Added to Metformin Monotherapy in Patients with Type 2 Diabetes
2015
Craig Coleman, Diana Sobieraj, Charles M White
Research Type: Poster/Presentation

Effets electrocardiographiques et hemodynamiques d'un supplement alimentaire multicompose contenant de l'ephedra et de la cafeine: Essai randomise et controle
2004
Brian F McBride, Craig Coleman, Charles M White, Jeffrey Kluger, Angeliki K Karapanos, Agnes Krudysz
Research Type: Journal Article

Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis.
2008
Charles M White, Craig Coleman, P Vachhani, C Teevan, K M Reinhart
Research Type: Journal Article

Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA.
2019
C Nguyen, H Tan, Craig Coleman, M Ingham, M Singhal, M Han
Research Type: Journal Article

Effectiveness of recombinant human growth hormone (rhGH) in the treatment of patients with cystic fibrosis
2010
Olivia J Phung, Jeffrey Kluger, Wendy T Chen, Erica L Baker, Jennifer E Girotto, Ripple Talati, Robert Quercia, Jennifer Scholle, Sagar S Makanji, Craig Coleman
Research Type: Journal Article

Effectiveness of high-versus low-dose four-factor prothrombin complex concentrate on hemostasis and thromboembolism in patients with oral factor Xa inhibitor-associated
2023
Craig Coleman
Research Type: Poster/Presentation

Effectiveness of High- Versus Low-Dose Four-Factor Prothrombin Complex Concentrate on Hemostasis and Thromboembolism in Patients with Oral Factor Xa Inhibitor-Associated Intracranial Hemorrhage
2023
Craig Coleman, William L Baker Jr.
Research Type: Poster/Presentation

Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and heart failure.
2019
D Eriksson, B K Martinez, Craig Coleman, A K Meinecke, Thomas Bunz, N A Sood
Research Type: Journal Article

Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease.
2019
D Eriksson, Craig Coleman, William L Baker Jr., B K Martinez, A K Meinecke, M J Alberts, Thomas Bunz
Research Type: Journal Article

Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
2019
D Eriksson, N A Sood, William L Baker Jr., Thomas Bunz, Craig Coleman
Research Type: Journal Article

Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: an administrative claims database analysis.
2018
Craig Coleman, D Eriksson, A K Meinecke, N A Sood, Thomas Bunz
Research Type: Journal Article

Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study.
2018
Thomas Bunz, W F Peacock, J Beyer-Westendorf, Craig Coleman
Research Type: Journal Article

Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism.
2018
Thomas Bunz, J Beyer-Westendorf, Craig Coleman
Research Type: Journal Article

Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data.
2021
Thomas Bunz, J Beyer-Westendorf, Craig Coleman, K T Moore, V Ashton, D Milentijevic, O S Costa
Research Type: Journal Article

Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
2017
Thomas Bunz, Craig Coleman
Research Type: Journal Article

Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism.
2020
Craig Coleman, Thomas Bunz, O S Costa, G H Lyman, N M Kuderer, C G Kohn
Research Type: Journal Article

Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes.
2019
N A Sood, Craig Coleman, Thomas Bunz, William L Baker Jr., A K Meinecke, D Eriksson, J Beyer-Westendorf
Research Type: Journal Article

Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state.
2018
Craig Coleman, J Beyer-Westendorf, William L Baker Jr., Thomas Bunz
Research Type: Journal Article

Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
2006
W E Boden, R G McKay, J F Mather, Craig Coleman, Charles M White
Research Type: Journal Article

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism.
2023
B Schaefer, S Fatoba, G Brobert, A Ekbom, M Rivera, G Psaroudakis, C Brescia, K Abdelgawwad, K S Caroti, C Becattini, Craig Coleman, M Carrier, A T Cohen, A A Khorana
Research Type: Journal Article